Seres Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Seres Therapeutics, Inc. (MCRB) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $20.71 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $20.71M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $32.94M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $35.46M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $38.05M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $20.71M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $32.94M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $35.46M 10-K · filed 2026-03-12 |
| 2025-09-30 | $38.05M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $40.70M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $43.42M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $46.21M 10-K · filed 2025-03-13 |
| 2024-09-30 | $49.06M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $58.26M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $61.58M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $64.96M 8-K · filed 2024-08-15 |
| 2023-09-30 | $67.39M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $70.73M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $72.28M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $75.63M 10-K · filed 2023-03-07 |
| 2022-09-30 | $8.51M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $9.13M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $9.75M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $7.17M 10-K · filed 2022-03-01 |
| 2020-12-31 | $2.33M 10-K · filed 2021-03-02 |
| 2019-12-31 | $4.18M 10-K · filed 2020-03-02 |
| 2019-09-30 | $4.71M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $5.28M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $5.87M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |